Literature DB >> 3087512

Morphine intoxication in renal failure: the role of morphine-6-glucuronide.

R J Osborne, S P Joel, M L Slevin.   

Abstract

Patients with impaired renal function may experience severe and prolonged respiratory depression when treated with morphine. This has been attributed to accumulation of the drug during renal failure. Three patients are described who had classical signs of intoxication with morphine in the absence of measurable quantities of morphine in the plasma. The observed clinical effect is attributed to accumulation of the pharmacologically active metabolite morphine-6-glucuronide, which is usually renally excreted. It is concluded that morphine does not accumulate in patients with renal failure but that accumulation of metabolites does occur. The previously reported observations of morphine accumulation during renal failure probably result from the use of radioimmunoassays that cannot distinguish between morphine and morphine-6-glucuronide. Thus the apparent morphine concentration measured with these assays in fact reflects the total quantity of morphine and morphine-6-glucuronide present.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087512      PMCID: PMC1340555          DOI: 10.1136/bmj.292.6535.1548

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

2.  Renal failure and the use of morphine in intensive care.

Authors:  M Ball; H J McQuay; R A Moore; M C Allen; A Fisher; J Sear
Journal:  Lancet       Date:  1985-04-06       Impact factor: 79.321

3.  Morphine-6-glucuronide, an important metabolite.

Authors:  S P Joel; R J Osborne; N S Nixon; M L Slevin
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

4.  Morphine-6-glucuronide, an important factor in interpreting morphine radioimmunoassays.

Authors:  G W Aherne; P Littleton
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

5.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography.

Authors:  J O Svensson; A Rane; J Säwe; F Sjöqvist
Journal:  J Chromatogr       Date:  1982-07-09
  5 in total
  61 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Sedation for fibreoptic bronchoscopy.

Authors:  M P Shelley; P Wilson; J Norman
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

Review 3.  Advances in opioid pharmacology.

Authors:  Geoffrey K Gourlay
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

Review 4.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

5.  Opiate toxicity in patients with renal failure.

Authors:  B R Conway; D G Fogarty; W E Nelson; C C Doherty
Journal:  BMJ       Date:  2006-02-11

6.  Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.

Authors:  J Hasselström; N Alexander; C Bringel; J O Svensson; J Säwe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Heroin intoxication: the relation between plasma morphine concentration and clinical state at admission.

Authors:  J Gutierrez-Cebollada; J Camí; R de la Torre
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  [The role of morphine-6-glucuronide during longterm administration of morphine.].

Authors:  M Prokopek; A Ziegler
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 9.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

10.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.